These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21940662)

  • 1. Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines.
    Zampell JC; Avraham T; Yoder N; Fort N; Yan A; Weitman ES; Mehrara BJ
    Am J Physiol Cell Physiol; 2012 Jan; 302(2):C392-404. PubMed ID: 21940662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation.
    Zampell JC; Yan A; Avraham T; Daluvoy S; Weitman ES; Mehrara BJ
    FASEB J; 2012 Mar; 26(3):1027-39. PubMed ID: 22067482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition.
    Yan A; Avraham T; Zampell JC; Haviv YS; Weitman E; Mehrara BJ
    Future Oncol; 2011 Dec; 7(12):1457-73. PubMed ID: 22112321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
    Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
    J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
    Blacker HA; Orgeig S
    J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The β
    Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.
    Zampell JC; Elhadad S; Avraham T; Weitman E; Aschen S; Yan A; Mehrara BJ
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C709-19. PubMed ID: 22049214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenic growth factors, receptors and therapies.
    Lohela M; Saaristo A; Veikkola T; Alitalo K
    Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.
    Baker A; Kim H; Semple JL; Dumont D; Shoichet M; Tobbia D; Johnston M
    Breast Cancer Res; 2010; 12(5):R70. PubMed ID: 20825671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
    Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
    Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High-Fat Diet in the Absence of Obesity Increases Lymphangiogenesis by Inducing VEGF-C in a Murine Lymphedema Model.
    Choi J; Kim J; Kim J; Jeong W; Jo T; Lee HW; Park YS; Park SW
    Plast Reconstr Surg; 2023 Jul; 152(1):87-96. PubMed ID: 36730763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
    Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-lymphangiogenic properties of IFN-γ-activated human dendritic cells.
    Gagliostro V; Seeger P; Garrafa E; Salvi V; Bresciani R; Bosisio D; Sozzani S
    Immunol Lett; 2016 May; 173():26-35. PubMed ID: 26987844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.
    Poyet C; Thomas L; Benoit TM; Delmo DA; Luberto L; Banzola I; Günthart MS; Sais G; Eberli D; Sulser T; Provenzano M
    Oncotarget; 2017 Mar; 8(13):21871-21883. PubMed ID: 28423532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.